How much is CRISPR Therapeutics AG stock worth?

On Monday morning 08/21/2023 the CRISPR Therapeutics AG share started trading at the price of $48.05. Compared to the closing price on Friday 08/18/2023 on NAS of $48.14, this is a drop of 0.19%. There are 79.41 M shares outstanding in CRISPR Therapeutics AG, which values the company at $3.75 B. Is CRISPR Therapeutics stock a Buy, Sell or Hold?

Does cprx pay a dividend?

No significant news for in the past two years. CPRX is not currently paying a regular dividend. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock quotes are delayed as per exchange requirements.

How does CRISPR Therapeutics (CRSP) perform in fiscal Q1 2023?

CRISPR Therapeutics GAAP EPS of -$0.67 beats by $0.97, revenue of $100M beats by $75.67M (NASDAQ:CRSP) CRISPR Therapeutics Stock Sees Relative Strength Rating Rise To 89 Fiscal Q1 2023 ended 3/31/23. Measures how much net income or profit is generated as a percentage of revenue.

Who is CRISPR Therapeutics?

Analyst Report: CRISPR Therapeutics AG CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics.